142 related articles for article (PubMed ID: 32705119)
1. Stability-Indicating RP-HPLC and CE Methods for Simultaneous Determination of Bisoprolol and Perindopril in Pharmaceutical Formulation: A Comparative Study.
Hassan SA; Nashat NW; Elghobashy MR; Abbas SS; Moustafa AA
J Chromatogr Sci; 2020 Aug; 58(8):747-758. PubMed ID: 32705119
[TBL] [Abstract][Full Text] [Related]
2. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
[TBL] [Abstract][Full Text] [Related]
3. Stability-indicating RP-HPLC method for the quantitative analysis of perindopril erbumine in tablet dosage form.
Dugga HH; Peraman R; Nayakanti D
J Chromatogr Sci; 2014 Apr; 52(4):315-20. PubMed ID: 23690066
[TBL] [Abstract][Full Text] [Related]
4. Fast RP-HPLC Method for the Determination of Bisoprolol.
Panainte AD; Vieriu M; Ţântaru G; Apostu M; Bibire N
Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):720-6. PubMed ID: 30152661
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a stability-indicating assay method for simultaneous determination of perindopril and indapamide in combined dosage form by reversed-phase high-performance liquid chromatography.
Jogia H; Khandelwal U; Gandhi T; Singh S; Modi D
J AOAC Int; 2010; 93(1):108-15. PubMed ID: 20334172
[TBL] [Abstract][Full Text] [Related]
6. Chromatographic Techniques for Assessment of Bisoprolol Fumarate and Perindopril Arginine in Solid Formulations under Various Stress Conditions and Application to Six Sigma, Content Uniformity, and Comparative Dissolution Approaches.
Mahmoud OA; Omran AA; Binsaleh AY; Almalki MA; Mohamed MA
J AOAC Int; 2023 Sep; 106(5):1165-1179. PubMed ID: 37341634
[TBL] [Abstract][Full Text] [Related]
7. Validated chromatographic methods for determination of perindopril and amlodipine in pharmaceutical formulation in the presence of their degradation products.
Zaazaa HE; Abbas SS; Essam HA; El-Bardicy MG
J Chromatogr Sci; 2013 Jul; 51(6):533-43. PubMed ID: 23112269
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of Stability Indicating High-Performance Liquid Chromatographic Method for Determination of Cyproheptadine Hydrochloride, its Impurity And Degradation Product.
Abdelrahman MM; Abdelaleem EA; Ali NW; Emam RA
J Chromatogr Sci; 2021 Jan; 59(2):128-133. PubMed ID: 33137815
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets.
Hassan SA; Elzanfaly ES; El-Zeany SB; Salem MY
Acta Pharm; 2016 Dec; 66(4):479-490. PubMed ID: 27749253
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.
Reddy PS; Sudhakar Babu K; Kumar N
J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of impurities level of perindopril tert-butylamine in tablets.
Medenica M; Ivanović D; Masković M; Jancić B; Malenović A
J Pharm Biomed Anal; 2007 Sep; 44(5):1087-94. PubMed ID: 17590561
[TBL] [Abstract][Full Text] [Related]
12. Stability Indicating RP-HPLC Method for Estimation of Potential Impurities in Ledipasvir and Characterization of a New Degradation Impurity.
Siva Kumar R; Sravan Kumar KV; Kondareddy L; Yogeshwara KR; Manish G; Jeenet J; Nitesh K
J Chromatogr Sci; 2018 May; 56(5):383-395. PubMed ID: 29474520
[TBL] [Abstract][Full Text] [Related]
13. Comparison of spectrophotometric and an LC method for the determination perindopril and indapamide in pharmaceutical formulations.
Erk N
J Pharm Biomed Anal; 2001 Aug; 26(1):43-52. PubMed ID: 11451641
[TBL] [Abstract][Full Text] [Related]
14. STABILITY-INDICATING HPLC METHOD FOR DETERMINATION OF VANCOMYCIN HYDROCHLORIDE IN THE PHARMACEUTICAL DOSAGE FORMS.
Serri A; Moghimp HR; Mahboubi A; Zarghi A
Acta Pol Pharm; 2017 Jan; 74(1):73-79. PubMed ID: 29474763
[TBL] [Abstract][Full Text] [Related]
15. Optimization of localized surface plasmon resonance hot spots in surface-enhanced infrared absorption spectroscopy aluminum substrate as an optical sensor coupled to chemometric tools for the purity assay of quinary mixtures.
Eid SM; Hassan SA; Nashat NW; Elghobashy MR; Abbas SS; Moustafa AA
Mikrochim Acta; 2021 May; 188(6):195. PubMed ID: 34021787
[TBL] [Abstract][Full Text] [Related]
16. Stability-Indicating RP-HPLC Method for the Estimation of Process-Related Impurities and Degradation Products in Fesoterodine Fumarate by Using a Mass Spectrometric Compatible Mobile Phase.
Kumar N; Sangeetha D; Kalyanraman L
J Chromatogr Sci; 2021 Jan; 59(2):154-164. PubMed ID: 33190158
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of amlodipine and bisoprolol in rat plasma by a liquid chromatography/tandem mass spectrometry method and its application in pharmacokinetic study.
Chang H; Li J; Li J; Guan X; Sun F; Qian Z; Bi K; Fan G
J Pharm Biomed Anal; 2012 Dec; 71():104-10. PubMed ID: 22947502
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
19. A validated stability-indicating RP-LC method for the simultaneous determination of amlodipine and perindopril in tablet dosage form and their stress degradation behavior under ICH-recommended stress conditions.
Gumustas M; Ozkan SA
J AOAC Int; 2013; 96(4):751-7. PubMed ID: 24000747
[TBL] [Abstract][Full Text] [Related]
20. Stability-indicating HPLC method for arteether and application to nanoparticles of arteether.
Gugulothu D; Patravale V
J Chromatogr Sci; 2014 Sep; 52(8):831-6. PubMed ID: 23983243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
